openPR Logo
Press release

Retinal Drugs And Biologics Market Poised to Expand at a Robust Pace Over 2027

01-08-2018 11:51 AM CET | Health & Medicine

Press release from: Future Market Insights

/ PR Agency: Future Market Insights
Retinal Drugs And Biologics Market Poised to Expand at a Robust

Retina is a very sensitive and delicate part of human eye which is responsible for receiving and processing light to convert into neural signals and send to the brain for visual activity. The disorders related to retinal health include age-related macular degeneration, diabetic retinopathy, infectious retinitis, macular edema, macular hole, retinoblastoma, retinal degeneration, retinoschisis and uveitis etc. There are various types of retinal disorders but most of them cause visual symptoms. For instance, age-related macular degeneration (AMD), the most common retinal disease is associated with aging. It is a leading cause of blindness among people over the age of 50. Diabetic retinopathy is another major retinal disease which is a result of complications of diabetes. Diabetes damage the tiny blood vessels of retina and blood or fluids start to leak out from the vessels. The treatment of retinal disorders include surgery and medicines.

Retinal Drugs and Biologics Market: Drivers and Restraints

The key contributor to the growth of global retinal drugs and biologics market is globally rising incidences of ophthalmic disorders related to age. Emergence of various innovative products in forms of biologics and drug releasing implants as a result of research and development and continuous efforts to invent treatment alternatives are contributing to the market growth. Introduction of biologics such as Lucentis to the ophthalmology field has represented a true paradigm shift in the treatment of patients. Lucentis has been successful in preserving vision in 90% of wet age related macular degeneration. However, the availability of limited number of biologics, severe side effects of biologics, strict regulatory norms associated with the approval of biologics, inaccessibility to the effective drugs and biologics due to high costs may limit the market growth.

Request to Sample Report - https://www.futuremarketinsights.com/reports/sample/rep-gb-4055

Retinal Drugs and Biologics Market: Segmentation

Global retinal drugs and biologics market has been segmented on the basis of types of conditions, types of therapies, distribution channels and region.

Based on types of conditions, the global retinal drugs and biologics market is segmented into:

Age related macular degeneration
Diabetic retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole

Based on the types of therapies, the global retinal drugs and biologics market is segmented into:

Surgery
Medicines
Intravitreal Injections
Medicines
Anti-VEGF Drugs
Ranibizumab
Bevacizumab
Aflibercept
Intravitreal Implant Releasing Steroids
Dexamethasone
Fluocinolone
Retinal Laser

Based on the distribution channels, the global Retinal Drugs and Biologics Market is segmented into:

Retail Pharmacies
Hospital Pharmacies
Specialty Ophthalmology Clinics

Retinal Drugs and Biologics Market: Overview

Global Retinal Drugs and Biologics market is highly fragmented with the presence of multiple players.Overall market is expected to report a sound growth as the epidemiologic studies have revealed that over 296 million people suffer from some type of retinal disease or condition globally, around 142 million people across the globe are impacted by age-related macular degeneration and approximately 105 million are affected by diabetic eye disease, these two diseases in combination are leading causes of vision loss globally.

Request Report TOC @ https://www.futuremarketinsights.com/toc/rep-gb-4055

Retinal Drugs and Biologics Market: Region-wise Outlook

Geographically, Retinal Drugs and Biologics Market is segmented into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. European countries have been witnessed highest incidence rates in case of retinal disorders followed by North America. The incidence rates of retinal diseases in Asia Pacific countries is comparatively less but it is increasing gradually, hence the market will show a gradual increase in this region. Diabetes also plays a significant role in retinal disease treatment market. The growing incidence rate of diabetes in developed countries due to sedentary life style and unhealthy habits is expected to fuel the market growth for retinal diseases drugs and biologics.

Retinal Drugs and Biologics Market: Key Players

Some of the players active in the global Retinal Drugs and Biologics Market include ALLERGAN, Alimera Sciences, AbbVie Inc., Janssen Biotech, Inc., Swedish Orphan Biovitrum, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Genzyme Corporation, Genentech USA, Inc., OCULAR THERAPEUTIX, INC. and Bausch & Lomb Incorporated and UCBCares.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website :www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Retinal Drugs And Biologics Market Poised to Expand at a Robust Pace Over 2027 here

News-ID: 889594 • Views:

More Releases from Future Market Insights

Extruded Snacks Market to Reach USD 170.3 Billion by 2035 Amid Health and Convenience Revolution
Extruded Snacks Market to Reach USD 170.3 Billion by 2035 Amid Health and Conven …
A new market analysis released today projects the global extruded snacks market to surge from an estimated USD 89.9 billion in 2025 to USD 170.3 billion by 2035, demonstrating a robust Compound Annual Growth Rate (CAGR) of 6.6%. The market is set to deliver an impressive absolute dollar opportunity of USD 80.4 billion over the forecast period, driven by a global consumer shift towards convenient, shelf-stable, and healthier snack options. The
Global Banana Flakes Market Soars to USD 876.1 million by 2035, Driven by Health & Clean-Label Trends
Global Banana Flakes Market Soars to USD 876.1 million by 2035, Driven by Health …
A new market analysis reveals the global banana flakes market is set to expand significantly, projecting a robust Compound Annual Growth Rate (CAGR) of 4.6% from 2025 to 2035. The market, valued at USD 559.6 million in 2025, is forecast to reach USD 876.1 million by 2035, fueled by a rising consumer preference for natural, gluten-free, and plant-based ingredients in daily food choices. This press release offers a detailed look into
Confectionery Fillings Market Sweetens Global Outlook, Projected to Reach USD 2.2 Billion by 2035
Confectionery Fillings Market Sweetens Global Outlook, Projected to Reach USD 2. …
The global confectionery fillings market is poised for significant growth, with a new market analysis revealing a robust expansion fueled by a surge in consumer demand for innovative flavors and indulgent textures. According to the analysis, the market is estimated at USD 1381.2 million in 2025 and is projected to reach USD 2207.4 million by 2035, exhibiting a healthy compound annual growth rate (CAGR) of 4.8% during the forecast period. The
Water Softener Market to Skyrocket to USD 8.7 Billion by 2035, Driven by Smart Technology and Hard Water Crisis
Water Softener Market to Skyrocket to USD 8.7 Billion by 2035, Driven by Smart T …
A new market analysis reveals the global water softener market is poised for significant expansion, with a forecasted value of USD 8.7 billion by 2035. The report, covering the period from 2025 to 2035, projects a robust Compound Annual Growth Rate (CAGR) of 8.3%, up from an estimated USD 3.9 billion valuation in 2025. This surge is fueled by a combination of factors, including increasing consumer awareness of hard water's

All 5 Releases


More Releases for Retina

Visual Prosthesis Market | Bionic Vision, Nano Retina, PIXIUM VISION, Retina Imp …
The global visual prosthesis market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the visual prosthesis market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the
Artificial Retina Market Revenue 2019: Nano-Retina, Second Sights
Product innovation is a key artificial retina market trend. The ophthalmic industry has become more competitive over the last few years. Established ophthalmic product categories have become more mature, in turn offering low level of market opportunity for players. Most companies are emphasizing on price level strategy in order to enhance their business presence worldwide. However, the pricing trend could potentially benefit the company on a shorter scale during the
Artificial Retina Market Key Players – Second Sight, Nano Retina, Retina Impla …
Artificial Retina manufacturers are making huge financial investments in R&D which is leading to new and innovative product development resulting in driving the growth for the market in turn. According to a recent study report published by the Market Research Future, The Global Market of Artificial Retina is growing steadily and is expected to continue its growth soon. Global Artificial Retina Market is expected to grow to US$ 102.9 million
Artificial Retina Market 2018: Advancement with Key Player – Second Sight, Nan …
Artificial Retina is new hope for blind people and helps blind person to see objects. Artificial retina is placed either in the internal surface of the retina or outer surface of retina. There are around 1.5 million people suffering from retinitis pigmentosa which ultimately causes blindness. Approximately, 280 million people with visual impairment and about 40 million people are completely blind. Global Artificial Retina Market - Key Players Some of the
Artificial Retina Market Insights With Key Players Nano-Retina, Second Sights, a …
Artificial retina market is a major breakthrough in medical devices industry, wherein many universities and leading medical devices companies are conducting research to offer vision to over 285 million visually impaired population worldwide. These devices are mainly nanorod carbon nanotube biomimetic films along with accessory devices such as transmitter and video processing unit (VPU). As such progressive development towards artificial retina is expected to create high ROI for engaged
Artificial Retina Market Unique Scenario by Key Vendors Like: Second Sight, Nano …
Global Market for Artificial Retina is growing steady and expected to continue its growth near future. Global Artificial Retina Market is expected to grow US$ 102.9 million by 2023 at CAGR of 2.1%. Global Artificial Retina Market - Key Players Some of the key players in this market are: Second Sight (US) Nano Retina (Israel) Retina Implant AG (Germany) Pixium Vision (France) Bionic Vision Australia Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2812 Global Artificial Retina Market - Segments Global Artificial Retina